|
CN104749289A
|
|
Method for detecting and separating pomalidomide related substances by use of high performance liquid chromatography
|
|
CN104288118A
|
|
Tenofovir disoproxil fumarate tablet and preparation method thereof
|
|
CN104042590A
|
|
Stable pomalidomide capsule and preparation method thereof
|
|
CN104447310A
|
|
Defluorinated flurbiprofen axetil compound, and preparation method, pharmaceutical composition and application thereof
|
|
CN104098471A
|
|
Dimethyl fumarate polymorph, preparation method thereof and pharmaceutical composition
|
|
CN104072567A
|
|
Dimeric androstane type compounds, and preparing method, pharmaceutical composition and applications thereof
|
|
CN104069075A
|
|
Abiraterone acetate tablet and preparing method thereof
|
|
CN104076097A
|
|
High performance liquid chromatography detecting method for abiraterone acetate and tablet of abiraterone acetate
|
|
CN103054815A
|
|
Tebipenem pivoxil oral solid preparation and preparation method thereof
|
|
CN103127041A
|
|
Medicinal composition with lanthanum acetate, preparation method and application thereof
|
|
CN103120654A
|
|
Application of lanthanum acetate or hydrates for treating hyperphosphatemia
|
|
CN102336801A
|
|
Abiraterone acetate polymorphic substance and pharmaceutical composition
|
|
CN102816145A
|
|
Methanesulfonic acid imatinib polymorphic substance and medical combination thereof
|
|
CN101781347A
|
|
Polymorphic substances of decitabine and medical compositions
|
|
CN102060746A
|
|
Synthesis method and intermediate of 3-(substituted dihydroisoindolinone-2-group)-2, 6-piperadinedione
|
